These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 9281598

  • 1. Ionizing radiation and teniposide increase p21(waf1/cip1) and promote Rb dephosphorylation but fail to suppress E2F activity in MCF-7 breast tumor cells.
    Orr MS, Watson NC, Sundaram S, Randolph JK, Jain PT, Gewirtz DA.
    Mol Pharmacol; 1997 Sep; 52(3):373-9. PubMed ID: 9281598
    [Abstract] [Full Text] [Related]

  • 2. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.
    Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
    Jiang Z, Liang P, Leng R, Guo Z, Liu Y, Liu X, Bubnic S, Keating A, Murray D, Goss P, Zacksenhaus E.
    Dev Biol; 2000 Nov 01; 227(1):8-41. PubMed ID: 11076674
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Control of E2F activity by p21Waf1/Cip1.
    Delavaine L, La Thangue NB.
    Oncogene; 1999 Sep 23; 18(39):5381-92. PubMed ID: 10498892
    [Abstract] [Full Text] [Related]

  • 12. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
    Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND.
    Int J Oncol; 1999 May 23; 14(5):869-75. PubMed ID: 10200336
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R, Cheng E, Zhang Y, Mandigo CE, Miglarese MR.
    Oncogene; 1998 May 14; 16(19):2489-501. PubMed ID: 9627115
    [Abstract] [Full Text] [Related]

  • 16. Activation of a retinoblastoma-protein-dependent pathway by sphingosine.
    Dbaibo GS, Wolff RA, Obeid LM, Hannun YA.
    Biochem J; 1995 Sep 01; 310 ( Pt 2)(Pt 2):453-9. PubMed ID: 7654183
    [Abstract] [Full Text] [Related]

  • 17. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM, Hu PP, Shen X, Yu Y, Wang XF.
    Proc Natl Acad Sci U S A; 1997 May 13; 94(10):4948-53. PubMed ID: 9144170
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
    Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM.
    Exp Cell Res; 1997 Aug 01; 234(2):293-9. PubMed ID: 9260897
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.